Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.
New research finds that retinal diseases thought to map one-to-one to genetic mutations are more complicated than that.
Retinal diseases are at the forefront of a quiet revolution in the realm of ophthalmology. Gene therapy, once a distant dream, is now emerging as a beacon of hope for millions affected by these ...
An international research team led by Prof. Dr. Sedat Nizamoğlu from the Department of Electrical and Electronics Engineering ...
Please provide your email address to receive an email when new articles are posted on . Errors of refraction and strabismic amblyopia were the most common causes of low vision. Retinal diseases most ...
Panelists discuss how emerging therapies—including TKIs, sustained-release implants, and gene therapy—may reduce treatment ...
Patients with retinal diseases who were treated with anti-VEGF therapies through manufacturer patient assistance programs ...
Nanoscope Therapeutics, Inc., a biotechnology company developing disease-agnostic therapies for vision loss caused by retinal degeneration, today announced that Japan's Ministry of Health, Labour and ...
Nanoscope Therapeutics has received Pioneering Regenerative Medical Product (Sakigake) and Orphan Drug designations for ...
Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with advanced dry macular degeneration. The hair-thin patch replaces damaged retinal ...
The blood-brain and blood-retinal barriers are protective systems that prevent harmful substances from entering the brain and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results